AGIO:NASDAQ
Agios Pharmaceuticals Inc
US$ 29.55
arrow_downward
-0.44%(-0.13) Siku 1
19 Nov, 11:38:24 GMT -5 · USD
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya AGIO...
Fungua
US$ 29.93
Juu
US$ 30.35
Chini
US$ 29.19
Mtaji wa soko
1.76B
Wastani wa kiasi cha mauzo
1.18M
Kiasi cha mauzo ya hisa
elfu 100.84
Juu kwa wiki 52
US$ 44.09
Chini kwa wiki 52
US$ 23.00
EPS
-US$ 6.32
Beta
0.66
Hisa za wawekezaji
59.81M
Idadi ya wafanyakazi
540
Fungua
US$ 29.93
Juu
US$ 30.35
Chini
US$ 29.19
Mtaji wa soko
1.76B
Wastani wa kiasi cha mauzo
1.18M
Kiasi cha mauzo ya hisa
elfu 100.84
Juu kwa wiki 52
US$ 44.09
Chini kwa wiki 52
US$ 23.00
EPS
-US$ 6.32
Beta
0.66
Hisa za wawekezaji
59.81M
Idadi ya wafanyakazi
540
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
Barron's
·
saa 4 zilizopita
S&P 500 Futures Rise in Premarket Trading; Credicorp, Intercorp Finl Svcs Lead
The Motley Fool
·
saa 12 zilizopita
The S&P 500 Just Ended a Run of 155 Trading Days Above Its 200-Day Average. Here's What Followed 34 Similar Runs Since 1950.
24/7 Wall St.
·
saa 4 zilizopita
4 S&P 500 Dividend Stocks Paying Shareholders More Than Their Free Cash Flow
Benzinga
·
saa 2 zilizopita
S&P 500 Gains 1%; US Initial Jobless Claims Edge Higher
Wasifu
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
Kuhusu Agios Pharmaceuticals Inc
Afisa Mkuu Mtendaji (CEO)-
Wafanyakazi540
Lilianzishwa2008
Makao makuu-
SektaHealth Care
Sekta-
Tovutiagios.com